- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Factor VIII Deficiency Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Factor VIII Deficiency Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hemophilia A Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Factor VIII Deficiency Treatment include Pfizer, Takeda, Bayer HealthCare, CSL, and Grifols, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Factor VIII Deficiency Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hemophilia A Drugs
Hemophilia A Inhibitors Treatment
Von Willebrand Disease Treatment
Market segment by Application, can be divided into
Hospitals
Clinics
Other
Market segment by players, this report covers
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Factor VIII Deficiency Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Factor VIII Deficiency Treatment, with revenue, gross margin and global market share of Factor VIII Deficiency Treatment from 2019 to 2022.
Chapter 3, the Factor VIII Deficiency Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Factor VIII Deficiency Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Factor VIII Deficiency Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
1.2 Classification of Factor VIII Deficiency Treatment by Type
1.2.1 Overview: Global Factor VIII Deficiency Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2021
1.2.3 Hemophilia A Drugs
1.2.4 Hemophilia A Inhibitors Treatment
1.2.5 Von Willebrand Disease Treatment
1.3 Global Factor VIII Deficiency Treatment Market by Application
1.3.1 Overview: Global Factor VIII Deficiency Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor VIII Deficiency Treatment Market Size & Forecast
1.5 Global Factor VIII Deficiency Treatment Market Size and Forecast by Region
1.5.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Factor VIII Deficiency Treatment Market Size by Region, (2017-2022)
1.5.3 North America Factor VIII Deficiency Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Factor VIII Deficiency Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Factor VIII Deficiency Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Factor VIII Deficiency Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Factor VIII Deficiency Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Factor VIII Deficiency Treatment Market Drivers
1.6.2 Factor VIII Deficiency Treatment Market Restraints
1.6.3 Factor VIII Deficiency Treatment Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Factor VIII Deficiency Treatment Product and Solutions
2.1.4 Pfizer Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Factor VIII Deficiency Treatment Product and Solutions
2.2.4 Takeda Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Takeda Recent Developments and Future Plans
2.3 Bayer HealthCare
2.3.1 Bayer HealthCare Details
2.3.2 Bayer HealthCare Major Business
2.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Product and Solutions
2.3.4 Bayer HealthCare Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bayer HealthCare Recent Developments and Future Plans
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Factor VIII Deficiency Treatment Product and Solutions
2.4.4 CSL Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 CSL Recent Developments and Future Plans
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Factor VIII Deficiency Treatment Product and Solutions
2.5.4 Grifols Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Grifols Recent Developments and Future Plans
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Factor VIII Deficiency Treatment Product and Solutions
2.6.4 Novo Nordisk Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Novo Nordisk Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche
2.7.1 F. Hoffmann-La Roche Details
2.7.2 F. Hoffmann-La Roche Major Business
2.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product and Solutions
2.7.4 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Factor VIII Deficiency Treatment Product and Solutions
2.8.4 Kedrion Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Kedrion Recent Developments and Future Plans
2.9 Octapharma
2.9.1 Octapharma Details
2.9.2 Octapharma Major Business
2.9.3 Octapharma Factor VIII Deficiency Treatment Product and Solutions
2.9.4 Octapharma Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Octapharma Recent Developments and Future Plans
2.10 Biogen Idec
2.10.1 Biogen Idec Details
2.10.2 Biogen Idec Major Business
2.10.3 Biogen Idec Factor VIII Deficiency Treatment Product and Solutions
2.10.4 Biogen Idec Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Biogen Idec Recent Developments and Future Plans
2.11 BioMarin Pharmaceutical
2.11.1 BioMarin Pharmaceutical Details
2.11.2 BioMarin Pharmaceutical Major Business
2.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Solutions
2.11.4 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 BioMarin Pharmaceutical Recent Developments and Future Plans
2.12 Sangamo Therapeutics
2.12.1 Sangamo Therapeutics Details
2.12.2 Sangamo Therapeutics Major Business
2.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.12.4 Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sangamo Therapeutics Recent Developments and Future Plans
2.13 Spark Therapeutics
2.13.1 Spark Therapeutics Details
2.13.2 Spark Therapeutics Major Business
2.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.13.4 Spark Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Spark Therapeutics Recent Developments and Future Plans
2.14 Swedish Orphan Biovitrum
2.14.1 Swedish Orphan Biovitrum Details
2.14.2 Swedish Orphan Biovitrum Major Business
2.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product and Solutions
2.14.4 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
2.15 Uniqure NV
2.15.1 Uniqure NV Details
2.15.2 Uniqure NV Major Business
2.15.3 Uniqure NV Factor VIII Deficiency Treatment Product and Solutions
2.15.4 Uniqure NV Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Uniqure NV Recent Developments and Future Plans
2.16 Amarna Therapeutics
2.16.1 Amarna Therapeutics Details
2.16.2 Amarna Therapeutics Major Business
2.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.16.4 Amarna Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Amarna Therapeutics Recent Developments and Future Plans
2.17 Dimension Therapeutics
2.17.1 Dimension Therapeutics Details
2.17.2 Dimension Therapeutics Major Business
2.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Product and Solutions
2.17.4 Dimension Therapeutics Factor VIII Deficiency Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Dimension Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Factor VIII Deficiency Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Factor VIII Deficiency Treatment Players Market Share in 2021
3.2.2 Top 10 Factor VIII Deficiency Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Factor VIII Deficiency Treatment Players Head Office, Products and Services Provided
3.4 Factor VIII Deficiency Treatment Mergers & Acquisitions
3.5 Factor VIII Deficiency Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Factor VIII Deficiency Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Factor VIII Deficiency Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Factor VIII Deficiency Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Factor VIII Deficiency Treatment Revenue by Type (2017-2028)
6.2 North America Factor VIII Deficiency Treatment Revenue by Application (2017-2028)
6.3 North America Factor VIII Deficiency Treatment Market Size by Country
6.3.1 North America Factor VIII Deficiency Treatment Revenue by Country (2017-2028)
6.3.2 United States Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Factor VIII Deficiency Treatment Revenue by Type (2017-2028)
7.2 Europe Factor VIII Deficiency Treatment Revenue by Application (2017-2028)
7.3 Europe Factor VIII Deficiency Treatment Market Size by Country
7.3.1 Europe Factor VIII Deficiency Treatment Revenue by Country (2017-2028)
7.3.2 Germany Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
7.3.3 France Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region
8.3.1 Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2017-2028)
8.3.2 China Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8.3.5 India Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Factor VIII Deficiency Treatment Revenue by Type (2017-2028)
9.2 South America Factor VIII Deficiency Treatment Revenue by Application (2017-2028)
9.3 South America Factor VIII Deficiency Treatment Market Size by Country
9.3.1 South America Factor VIII Deficiency Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country
10.3.1 Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Factor VIII Deficiency Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Factor VIII Deficiency Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Factor VIII Deficiency Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Factor VIII Deficiency Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Factor VIII Deficiency Treatment Revenue Market Share by Region (2023-2028)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Factor VIII Deficiency Treatment Product and Solutions
Table 9. Pfizer Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Takeda Corporate Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Factor VIII Deficiency Treatment Product and Solutions
Table 13. Takeda Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bayer HealthCare Corporate Information, Head Office, and Major Competitors
Table 15. Bayer HealthCare Major Business
Table 16. Bayer HealthCare Factor VIII Deficiency Treatment Product and Solutions
Table 17. Bayer HealthCare Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. CSL Corporate Information, Head Office, and Major Competitors
Table 19. CSL Major Business
Table 20. CSL Factor VIII Deficiency Treatment Product and Solutions
Table 21. CSL Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Grifols Corporate Information, Head Office, and Major Competitors
Table 23. Grifols Major Business
Table 24. Grifols Factor VIII Deficiency Treatment Product and Solutions
Table 25. Grifols Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 27. Novo Nordisk Major Business
Table 28. Novo Nordisk Factor VIII Deficiency Treatment Product and Solutions
Table 29. Novo Nordisk Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 31. F. Hoffmann-La Roche Major Business
Table 32. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product and Solutions
Table 33. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Kedrion Corporate Information, Head Office, and Major Competitors
Table 35. Kedrion Major Business
Table 36. Kedrion Factor VIII Deficiency Treatment Product and Solutions
Table 37. Kedrion Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Octapharma Corporate Information, Head Office, and Major Competitors
Table 39. Octapharma Major Business
Table 40. Octapharma Factor VIII Deficiency Treatment Product and Solutions
Table 41. Octapharma Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Biogen Idec Corporate Information, Head Office, and Major Competitors
Table 43. Biogen Idec Major Business
Table 44. Biogen Idec Factor VIII Deficiency Treatment Product and Solutions
Table 45. Biogen Idec Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. BioMarin Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. BioMarin Pharmaceutical Major Business
Table 48. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product and Solutions
Table 49. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Sangamo Therapeutics Major Business
Table 52. Sangamo Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 53. Sangamo Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Spark Therapeutics Major Business
Table 56. Spark Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 57. Spark Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Swedish Orphan Biovitrum Corporate Information, Head Office, and Major Competitors
Table 59. Swedish Orphan Biovitrum Major Business
Table 60. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product and Solutions
Table 61. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Uniqure NV Corporate Information, Head Office, and Major Competitors
Table 63. Uniqure NV Major Business
Table 64. Uniqure NV Factor VIII Deficiency Treatment Product and Solutions
Table 65. Uniqure NV Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Amarna Therapeutics Corporate Information, Head Office, and Major Competitors
Table 67. Amarna Therapeutics Major Business
Table 68. Amarna Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 69. Amarna Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Dimension Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Dimension Therapeutics Major Business
Table 72. Dimension Therapeutics Factor VIII Deficiency Treatment Product and Solutions
Table 73. Dimension Therapeutics Factor VIII Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Factor VIII Deficiency Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Factor VIII Deficiency Treatment Players Head Office, Products and Services Provided
Table 78. Factor VIII Deficiency Treatment Mergers & Acquisitions in the Past Five Years
Table 79. Factor VIII Deficiency Treatment New Entrants and Expansion Plans
Table 80. Global Factor VIII Deficiency Treatment Revenue (USD Million) by Type (2017-2022)
Table 81. Global Factor VIII Deficiency Treatment Revenue Share by Type (2017-2022)
Table 82. Global Factor VIII Deficiency Treatment Revenue Forecast by Type (2023-2028)
Table 83. Global Factor VIII Deficiency Treatment Revenue by Application (2017-2022)
Table 84. Global Factor VIII Deficiency Treatment Revenue Forecast by Application (2023-2028)
Table 85. North America Factor VIII Deficiency Treatment Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Factor VIII Deficiency Treatment Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Factor VIII Deficiency Treatment Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Factor VIII Deficiency Treatment Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Factor VIII Deficiency Treatment Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Factor VIII Deficiency Treatment Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Factor VIII Deficiency Treatment Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Factor VIII Deficiency Treatment Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Factor VIII Deficiency Treatment Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Factor VIII Deficiency Treatment Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Factor VIII Deficiency Treatment Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Factor VIII Deficiency Treatment Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Factor VIII Deficiency Treatment Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Factor VIII Deficiency Treatment Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Factor VIII Deficiency Treatment Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Factor VIII Deficiency Treatment Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Factor VIII Deficiency Treatment Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Factor VIII Deficiency Treatment Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Factor VIII Deficiency Treatment Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Factor VIII Deficiency Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Factor VIII Deficiency Treatment Picture
Figure 2. Global Factor VIII Deficiency Treatment Revenue Market Share by Type in 2021
Figure 3. Hemophilia A Drugs
Figure 4. Hemophilia A Inhibitors Treatment
Figure 5. Von Willebrand Disease Treatment
Figure 6. Factor VIII Deficiency Treatment Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Factor VIII Deficiency Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Factor VIII Deficiency Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Factor VIII Deficiency Treatment Revenue Market Share by Region (2017-2028)
Figure 13. Global Factor VIII Deficiency Treatment Revenue Market Share by Region in 2021
Figure 14. North America Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Factor VIII Deficiency Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Factor VIII Deficiency Treatment Market Drivers
Figure 20. Factor VIII Deficiency Treatment Market Restraints
Figure 21. Factor VIII Deficiency Treatment Market Trends
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Takeda Recent Developments and Future Plans
Figure 24. Bayer HealthCare Recent Developments and Future Plans
Figure 25. CSL Recent Developments and Future Plans
Figure 26. Grifols Recent Developments and Future Plans
Figure 27. Novo Nordisk Recent Developments and Future Plans
Figure 28. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 29. Kedrion Recent Developments and Future Plans
Figure 30. Octapharma Recent Developments and Future Plans
Figure 31. Biogen Idec Recent Developments and Future Plans
Figure 32. BioMarin Pharmaceutical Recent Developments and Future Plans
Figure 33. Sangamo Therapeutics Recent Developments and Future Plans
Figure 34. Spark Therapeutics Recent Developments and Future Plans
Figure 35. Swedish Orphan Biovitrum Recent Developments and Future Plans
Figure 36. Uniqure NV Recent Developments and Future Plans
Figure 37. Amarna Therapeutics Recent Developments and Future Plans
Figure 38. Dimension Therapeutics Recent Developments and Future Plans
Figure 39. Global Factor VIII Deficiency Treatment Revenue Share by Players in 2021
Figure 40. Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Factor VIII Deficiency Treatment Revenue Market Share in 2021
Figure 42. Global Top 10 Players Factor VIII Deficiency Treatment Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Factor VIII Deficiency Treatment Revenue Share by Type in 2021
Figure 45. Global Factor VIII Deficiency Treatment Market Share Forecast by Type (2023-2028)
Figure 46. Global Factor VIII Deficiency Treatment Revenue Share by Application in 2021
Figure 47. Global Factor VIII Deficiency Treatment Market Share Forecast by Application (2023-2028)
Figure 48. North America Factor VIII Deficiency Treatment Sales Market Share by Type (2017-2028)
Figure 49. North America Factor VIII Deficiency Treatment Sales Market Share by Application (2017-2028)
Figure 50. North America Factor VIII Deficiency Treatment Revenue Market Share by Country (2017-2028)
Figure 51. United States Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Factor VIII Deficiency Treatment Sales Market Share by Type (2017-2028)
Figure 55. Europe Factor VIII Deficiency Treatment Sales Market Share by Application (2017-2028)
Figure 56. Europe Factor VIII Deficiency Treatment Revenue Market Share by Country (2017-2028)
Figure 57. Germany Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Factor VIII Deficiency Treatment Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Factor VIII Deficiency Treatment Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Factor VIII Deficiency Treatment Revenue Market Share by Region (2017-2028)
Figure 65. China Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Factor VIII Deficiency Treatment Sales Market Share by Type (2017-2028)
Figure 72. South America Factor VIII Deficiency Treatment Sales Market Share by Application (2017-2028)
Figure 73. South America Factor VIII Deficiency Treatment Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Factor VIII Deficiency Treatment Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Factor VIII Deficiency Treatment Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Factor VIII Deficiency Treatment Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Factor VIII Deficiency Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
